GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lombard Medical EVARF · USD

Health Care · US listing · 🇺🇸 United States

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2016

Revenue

$12.2m

FY2014FY2016

Net income

−$31.0m

FY2014FY2016

Free cash flow

−$26.9m

FY2014FY2016

Shareholders' equity

$14.0m

FY2014FY2016

Income statement

Fiscal years

FY2016FY2015FY2014
Revenue$12.2m$15.1m$13.3m
Research and development$7.5m$11.0m$9.2m
Operating income−$29.3m−$39.5m−$34.6m
Net income−$31.0m−$37.8m−$34.8m
Diluted earnings per share-1.49-1.82-1.67

Balance sheet

At each fiscal year end

FY2016FY2015FY2014
Total assets$67.8m$85.7m$72.9m
Cash and short-term investments$20.8m$32.3m—
Total liabilities$53.8m$42.6m$8.1m
Debt$32.3m$23.1m$5.3m
Shareholders' equity$14.0m$43.1m$64.8m
Shares outstanding21m21m21m

Cash flow

Fiscal years

FY2016FY2015FY2014
Cash from operations−$26.6m−$34.4m−$34.4m
Capital spending−$265,000−$1.3m−$1.5m
Free cash flow−$26.9m−$35.7m−$35.9m

Latest quarters

By quarter end

Sept 2017Jun 2017Dec 2016Sept 2016Jun 2016Mar 2016Dec 2015Sept 2015
Revenue$1.8m$2.7m$2.4m$3.0m$3.8m$2.9m$2.9m$4.2m
Operating income——−$4.1m−$6.8m−$7.3m−$7.3m——
Net income——−$7.7m−$7.4m−$8.3m−$7.6m——
Diluted earnings per share——-0.37-0.36-0.40-0.37——
Cash from operations——−$2.0m−$4.0m−$9.0m−$8.0m——
Capital spending——————−$1.0m−$1.0m
Total assets——$67.8m$64.1m$68.3m$76.8m$85.7m$91.4m
Debt——$34.6m$26.1m$23.4m$46.5m$23.0m$17.1m
Shareholders' equity——$14.0m$17.7m$25.5m$34.8m$43.1m$54.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue20.5%13.6%—
Operating income13.6%9.9%—
Net income17.4%13.9%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-252.2%-259.8%——
Net margin-252.3%-258.4%——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%-96%1073561%536522%9491%16384%-78%-45%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.